You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. SBIR Phase I:A compact, 3-level, high efficiency, 4-port, modular universal power conversion system with Internet of Things (IOT) using Wide Bandgap (WBG) devices

    SBC: Midwest Electric Propulsion Company (MEPCO)            Topic: EN

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project focuses on developing a universal power conversion system that addresses the unmet needs of the fast-growing electrification and energy storage industries whether it is related to electric vehicles (EV), EV charging, EV charging infrastructure, grid storage, or electric boat applications. The proposed ...

    SBIR Phase I 2023 National Science Foundation
  2. SBIR Phase I:Creation of antimicrobial MyoMatrix for functional muscle regeneration in a porcine model of volumetric muscle loss

    SBC: GENASSIST INC            Topic: BM

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop an antimicrobial muscle-regenerating biomaterial into a commercial-ready product and address volumetric muscle loss injuries. In the context of defense medicine, severe muscle trauma often occurs in environments where external factors such as sterility are not well-controlled. Th ...

    SBIR Phase I 2023 National Science Foundation
  3. SBIR Phase I:Directed evolution of site-specific bacterial transposase genes to alter specificity and efficiency of insertion of large DNA segments into restorable gene fusions

    SBC: SYNTHETIC VECTOR DESIGNS, LLC            Topic: BT

    The broader impact of this Small Business Innovation Research (SBIR) Phase I project will be to develop methods to facilitate the efficient, reproducible insertion of large DNA segments into stable locations on bacterial vectors, viral and non-viral shuttle vectors, and the chromosomes of prokaryotic and eukaryotic host cells comprising novel target sequences plus helper and donor vectors that cou ...

    SBIR Phase I 2023 National Science Foundation
  4. SBIR Phase I:Structure-guided design of anti-inflammatory modulators of protease-activated receptor 1 (PAR1)

    SBC: Function Therapeutics, Inc.            Topic: PT

    The broader impact of this Small Business Innovation Research (SBIR) Phase I project is that a deeper structural understanding will be developed of protease-activated receptor 1 (PAR1), an important target for promising new anti-thrombotic and anti-inflammatory drugs. The project will also support the development of new compounds targeting PAR1 with the potential for improved potency and safety pr ...

    SBIR Phase I 2023 National Science Foundation
  5. SBIR Phase I: Reactive Cyclic Induction Marine Diesel Emissions Reduction Monitoring and Delivery System Project

    SBC: STec. Technology, Inc.            Topic: ET

    The broader impact of this Small Business Innovation Research (SBIR) Phase I project is the potential reduction of toxic nitrogen oxides (NOx) and harmful carbon dioxide (CO2) emissions from marine diesel engines. There are approximately 4 million diesel-powered craft in use globally, emitting approximately one billion tons of CO2 and 100 million tons of NOx annually. This project seeks to remove ...

    SBIR Phase I 2023 National Science Foundation
  6. SBIR Phase II: Building Mathematical Thinking and Problem-solving Skills Together Through Play

    SBC: MATHBRIX LLC            Topic: LC

    This SBIR Phase I project will develop a machine learning-assisted family math preparation program that will help and encourage parents to provide early math instruction to young children, ages 4-8. Along with reading, developing mathematical proficiency is arguably one of the most important skills for young children to acquire, particularly with the growing importance of STEM (science, technology ...

    SBIR Phase II 2023 National Science Foundation
  7. SBIR Phase II:Smart Shunt to Treat Hydrocephalus

    SBC: Madison Scientific, Inc.            Topic: MD

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is the development of an advanced electromechanical cerebrospinal fluid (CSF) shunt system for the treatment and monitoring of hydrocephalus. Hydrocephalus is caused by an accumulation of CSF occurs within the brain, often causing an increased pressure inside the skull. Most shunts used to re ...

    SBIR Phase II 2023 National Science Foundation
  8. STTR Phase I:Next-Gen Radiofrequency Transistors on Silicon via Aligned, Residue-Free Carbon Nanotubes

    SBC: SIXLINE SEMICONDUCTOR, INC.            Topic: S

    The broader/commercial impact of this Small Business Technology Transfer (STTR) Phase I project seeks to overcome the highest risks facing the commercialization of a novel semiconductor for wireless communications devices. As the demand for wireless communication increases (e.g., cell phones, WiFi, Internet of Things devices), wireless component suppliers and manufacturers must utilize new materia ...

    STTR Phase I 2023 National Science Foundation
  9. Clinical biomarker for early prediction of chemotherapy-induced peripheral neuropathy

    SBC: NEWVENTUREIQ LLC            Topic: 102

    Project Summary / Abstract Chemotherapy induced peripheral neuropathy (CIPN) is a major side effect of oxaliplatin, a key drug in 1st line regimens for treating colorectal cancer. Dose-limiting CIPN prevents rt25% of patients from receiving full, maximally effective dose of oxaliplatin. In addition, 10-40% of patients receiving oxaliplatin-based therapy for colorectal cancer with develop chronic C ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. 3D force sensing insoles for wearable, AI empowered, high-fidelity gait monitoring

    SBC: Axioforce LLC            Topic: NIBIB

    PROJECT SUMMARYLoss of functional mobility associated with aging is the leading cause of dangerous falls and loss of living independence. Approximately 60% of community-residing individuals rt80 years-old have a gait disorder, and abnormal gait patterns are associated with a greater than two-fold increased risk of institutionalization and death in comparison to age-related adults without gait impa ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government